论文部分内容阅读
随着抗生素的广泛使用,细菌的耐药性日益严重,尤其是多重耐药菌,如耐甲氧西林金葡菌(MRSA)和耐万古霉素肠球菌(VRE)不断产生,引发严重的院内感染,危及患者的生命。多药耐药菌感染的诊治面临很大的挑战,链阳性菌素的出现缓解了此问题。通过查阅文献与临床调查等收集链阳性菌素类药物信息,进而对其国内外市场信息与研发动态进行分析,并预测链阳性菌素类药物的市场前景,为政府宏观调控及相关生产企业立项、选题、借鉴,提供参考依据。
With the widespread use of antibiotics, bacterial resistance is increasingly serious, especially multi-drug resistant bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) continue to produce, causing serious in the hospital Infected, endangering the lives of patients. The diagnosis and treatment of multidrug-resistant bacterial infections are facing great challenges. The emergence of streptogramin alleviates this problem. Through reviewing the literature and clinical investigation, we collected the information of streptogramin and further analyzed the market information and R & D dynamics both at home and abroad. We also predicted the market prospects of streptogramin and provided suggestions to government macro-control and related manufacturing enterprises , Topics, learn from, provide reference.